34.56
price down icon1.23%   -0.50
 
loading
Vericel Corp stock is traded at $34.56, with a volume of 59,346. It is down -1.23% in the last 24 hours and up +6.74% over the past month. Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
See More
Previous Close:
$35.06
Open:
$34.88
24h Volume:
59,346
Relative Volume:
0.09
Market Cap:
$1.75B
Revenue:
$249.12M
Net Income/Loss:
$7.11M
P/E Ratio:
277.37
EPS:
0.1246
Net Cash Flow:
$-8.30M
1W Performance:
-5.05%
1M Performance:
+6.74%
6M Performance:
-11.10%
1Y Performance:
-21.28%
1-Day Range:
Value
$34.45
$35.09
1-Week Range:
Value
$33.76
$36.99
52-Week Range:
Value
$29.24
$63.00

Vericel Corp Stock (VCEL) Company Profile

Name
Name
Vericel Corp
Name
Phone
(734) 930-5555
Name
Address
64 SIDNEY ST., CAMBRIDGE, MA
Name
Employee
357
Name
Twitter
@VericelCorp
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
VCEL's Discussions on Twitter

Compare VCEL with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
VCEL
Vericel Corp
34.66 1.77B 249.12M 7.11M -8.30M 0.1246
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
422.97 109.11B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
632.67 68.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
435.39 60.25B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
826.90 50.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
181.94 40.44B 447.02M -1.18B -868.57M -6.1812

Vericel Corp Stock (VCEL) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-17-25 Downgrade BTIG Research Buy → Neutral
Aug-09-24 Initiated Canaccord Genuity Buy
Jun-20-24 Initiated TD Cowen Buy
Jan-25-24 Upgrade Truist Hold → Buy
Aug-08-23 Upgrade BTIG Research Neutral → Buy
Nov-10-22 Downgrade BTIG Research Buy → Neutral
Nov-09-22 Downgrade Truist Buy → Hold
Oct-14-22 Resumed Stephens Overweight
Jan-11-21 Downgrade Oppenheimer Outperform → Perform
Dec-18-20 Initiated Stephens Overweight
Sep-17-20 Initiated Truist Buy
Oct-09-19 Initiated H.C. Wainwright Buy
Feb-28-19 Downgrade Needham Buy → Hold
Aug-08-18 Reiterated Needham Buy
Jul-16-18 Upgrade Ladenburg Thalmann Neutral → Buy
Apr-04-18 Initiated Leerink Partners Outperform
Mar-06-18 Downgrade Ladenburg Thalmann Buy → Neutral
Mar-06-18 Reiterated Needham Buy
Mar-05-18 Reiterated BTIG Research Buy
Jun-21-17 Initiated BTIG Research Buy
Mar-13-17 Reiterated Needham Buy
Dec-22-16 Initiated Piper Jaffray Overweight
Nov-09-16 Reiterated Needham Buy
Apr-05-16 Downgrade BofA/Merrill Buy → Neutral
Mar-11-16 Upgrade Needham Hold → Buy
View All

Vericel Corp Stock (VCEL) Latest News

pulisher
Nov 02, 2025

Can Vericel Corporation stock sustain market leadershipStop Loss & Fast Momentum Entry Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Vericel Corporation hit a new high this monthLayoff News & Community Verified Watchlist Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Geneva Capital Management LLC Acquires 419,183 Shares of Vericel Corporation $VCEL - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

Vericel’s Pivotal Earnings Report Approaches - AD HOC NEWS

Nov 01, 2025
pulisher
Nov 01, 2025

Heatmap analysis for Vericel Corporation and competitorsBuy Signal & Fast Moving Stock Watchlists - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Vericel (VCEL) to Release Quarterly Earnings on Thursday - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Strategies to average down on Vericel CorporationJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

InvestingPro’s fair value model correctly flagged Vericel’s 35% decline By Investing.com - Investing.com

Oct 30, 2025
pulisher
Oct 28, 2025

Is Vericel Corporation stock attractive after correctionWeekly Stock Analysis & Safe Entry Trade Reports - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Advanced analytics toolkit walkthrough for Vericel CorporationTrend Reversal & Fast Exit/Entry Strategy Plans - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Measuring Vericel Corporation’s beta against major indices2025 Bull vs Bear & Safe Capital Growth Tips - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How Vericel Corporation (ATQP) stock reacts to fiscal policies2025 Major Catalysts & Fast Gain Swing Trade Alerts - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

How Vericel Corporation stock performs in weak economyMarket Rally & Risk Managed Investment Strategies - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

What dividend safety score for Vericel Corporation stockBull Run & Risk Managed Trade Strategies - newser.com

Oct 27, 2025
pulisher
Oct 26, 2025

4,784 Shares in Vericel Corporation $VCEL Purchased by Vanguard Personalized Indexing Management LLC - Defense World

Oct 26, 2025
pulisher
Oct 26, 2025

Vericel Corporation $VCEL Shares Bought by Kornitzer Capital Management Inc. KS - MarketBeat

Oct 26, 2025
pulisher
Oct 26, 2025

Will Vericel Corporation (ATQP) stock beat revenue estimatesGap Down & Long-Term Investment Growth Plans - newser.com

Oct 26, 2025
pulisher
Oct 25, 2025

Vericel (NASDAQ:VCEL) Given "Sell (D+)" Rating at Weiss Ratings - MarketBeat

Oct 25, 2025
pulisher
Oct 23, 2025

Vericel Corp. Experiences Revision in Its Stock Evaluation Amid Complex Financial Landscape - Markets Mojo

Oct 23, 2025
pulisher
Oct 23, 2025

Vericel showcases cell-based procedure at AOAO meeting - Traders Union

Oct 23, 2025
pulisher
Oct 23, 2025

Vericel to Report Third-Quarter 2025 Financial Results on November 6, 2025 - The Manila Times

Oct 23, 2025
pulisher
Oct 23, 2025

Vericel (NASDAQ:VCEL) to report Q3 2025; conference call and webcast on Nov. 6 - Stock Titan

Oct 23, 2025
pulisher
Oct 23, 2025

Yousif Capital Management LLC Raises Stock Holdings in Vericel Corporation $VCEL - Defense World

Oct 23, 2025
pulisher
Oct 23, 2025

What dividend safety rating applies to Vericel Corporation (ATQP) stockTrade Risk Report & Free High Return Stock Watch Alerts - newser.com

Oct 23, 2025
pulisher
Oct 22, 2025

Here’s Why Vericel Corporation (VCEL) Underperformed in Q3 - Insider Monkey

Oct 22, 2025
pulisher
Oct 21, 2025

Why Vericel Corporation (ATQP) stock fits value portfoliosJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com

Oct 21, 2025
pulisher
Oct 20, 2025

Truist Lowers PT on Vericel Corporation (VCEL) to $41 From $46 - Insider Monkey

Oct 20, 2025
pulisher
Oct 20, 2025

Will Vericel Corporation see short term momentumInsider Selling & Verified Entry Point Signals - newser.com

Oct 20, 2025

Vericel Corp Stock (VCEL) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.23
price down icon 0.68%
$92.89
price down icon 0.72%
$28.92
price up icon 0.96%
$104.23
price up icon 0.19%
biotechnology ONC
$312.02
price up icon 0.74%
$182.66
price down icon 3.82%
Cap:     |  Volume (24h):